DRNA

Dicerna Pharmaceuticals, Inc.
DRNA

Delisted

DRNA was delisted on the 27th of December, 2021.

72 hedge funds and large institutions have $391M invested in Dicerna Pharmaceuticals, Inc. in 2018 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 16 increasing their positions, 16 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more funds holding

Funds holding:

more capital invested

Capital invested by funds: $ → $

0% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 16

98% less call options, than puts

Call options by funds: $20K | Put options by funds: $1.19M

Holders
72
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
8
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$20K
Puts
$1.19M
Net Calls
Net Calls Change

Top Buyers

1 +$6.13M
2 +$5.68M
3 +$4.3M
4
AG
Artal Group
Luxembourg
+$4.06M
5
Millennium Management
Millennium Management
New York
+$3.26M

Top Sellers

1 -$9.87M
2 -$4.06M
3 -$4.01M
4
Renaissance Technologies
Renaissance Technologies
New York
-$2.59M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$2.39M
Name Holding Trade Value Shares
Change
Change in
Stake
76
77
78